Table 4.
Step‐wise Models of the Relation of Risk Factors to Digital Vascular Measures
| Characteristic | BPA | PAT Ratio | PAT‐AIx | ||||||
|---|---|---|---|---|---|---|---|---|---|
| β (SE) | Partial R2 | P Value | β (SE) | Partial R2 | P Value | β (SE) | Partial R2 | P Value | |
| Sex (F=0, M=1) | 0.56 (0.04) | 0.149 | <0.0001 | −0.20 (0.02) | 0.084 | <0.0001 | −9.31 (0.99) | 0.202 | <0.0001 |
| Age | 0.01 (0.01) | 0.005 | −0.01 (0.01) | 0.35 | 0.53 (0.05) | <0.0001 | |||
| Systolic BP | — | — | — | 0.01(0.01) | 0.004 | 0.003 | 0.15(0.04) | 0.039 | <0.0001 |
| Diastolic BP | — | — | — | — | — | — | 0.20 (0.06) | 0.005 | 0.001 |
| Heart rate | — | — | — | — | — | — | −0.50 (0.04) | 0.069 | <0.0001 |
| Height | — | — | — | — | — | — | −0.24 (0.05) | 0.008 | <0.0001 |
| BMI | 0.04 (0.01) | 0.061 | <0.0001 | −0.01 (0.01) | 0.030 | <0.0001 | −0.58 (0.08) | 0.019 | <0.0001 |
| Total/HDL cholesterol | 0.05 (0.02) | 0.002 | 0.04 | −0.04 (0 .01) | 0.008 | <0.0001 | — | — | — |
| Triglygerides | 0.12 (0.05) | 0.011 | 0.01 | — | — | — | — | — | — |
| Smoking | — | — | — | — | — | — | 10.39 (1.05) | 0.041 | <0.0001 |
| Hypertensive treatment | — | — | — | −0.05 (0.02) | 0.003 | 0.03 | — | — | — |
| Prevalent CVD | — | — | — | −0.16 (0.05) | 0.008 | <0.0001 | −3.55 (1.72) | 0.002 | 0.01 |
| Model R | 0.22 | 0.14 | 0.38 | ||||||
BMI indicates body mass index; BP, blood pressure; BPA, baseline pulse amplitude; CVD, cardiovascular disease; F, female; HDL, high‐density lipoprotein; M, male; PAT, peripheral arterial tonometry; PAT‐AIx, augmentation index derived from PAT.